GlucoTrack And 2 Other Stocks Under $1 Insiders Are Buying
GlucoTrack And 2 Other Stocks Under $1 Insiders Are Buying
内部人士正在买入GlucoTrack和其他2只低于1美元的股票
The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道琼斯指数周三收盘下跌约0.1％。当内部人士购买或出售股票时，这表明他们对公司前景的信心或担忧。对细价股感兴趣的投资者和交易者可以将此视为他们整体投资或交易决策的一个因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是细价股最近几笔值得注意的内幕交易。欲了解更多信息，请访问Benzinga的内幕交易平台。
Tecogen
Tecogen
- The Trade: Tecogen Inc. (OTC:TGEN) Director Earl R Lewis bought a total of 10,000 shares at an average price of $0.68. To acquire these shares, it cost around $6,800. The company's Director John Hatsopoulos also bought 5,000 shares.
- What's Happening: Tecogen is expected to release first-quarter financial results on Thursday, May 9.
- What Tecogen Does: Tecogen Inc, designs, manufactures, markets, and maintains high-efficiency, ultra-clean cogeneration products. It operates in three business segments, namely Products, Services, and Energy Production.
- 交易：Tecogen Inc.（场外交易代码：TGEN）董事厄尔·刘易斯共购买了1万股股票，平均价格为0.68美元。收购这些股票的成本约为6,800美元。该公司董事约翰·哈索普洛斯还购买了5,000股股票。
- 发生了什么：Tecogen预计将于5月9日星期四发布第一季度财务业绩。
- Tecogen做什么：Tecogen公司设计、制造、销售和维护高效、超清洁的热电联产产品。它分为三个业务领域，即产品、服务和能源生产。
Bespoke Extracts
定制提取物
- The Trade: Bespoke Extracts, Inc. (OTC:BSPK) CEO Michael Feinsod acquired a total of 5,000 shares at an average price of $0.11. To acquire these shares, it cost around $550.
- What's Happening: The company's stock lost around 22% over the past six months.
- What Bespoke Extracts Does: Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products.
- 交易：Bespoke Extracts, Inc.（场外交易代码：BSPK）首席执行官迈克尔·费恩索德共收购了5,000股股票，平均价格为0.11美元。收购这些股票的成本约为550美元。
- 发生了什么：该公司的股票在过去六个月中下跌了约22％。
- Bespoke Extracts的作用：Bespoke Extracts Inc专注于销售其专有系列的特殊配方、优质、大麻衍生的CBD产品。
GlucoTrack
血糖追踪
- The Trade: GlucoTrack, Inc. (NASDAQ:GCTK) Director Drew Sycoff acquired a total of 182,540 shares at an average price of $1.26. The insider spent around $230,000 to buy those shares.
- What's Happening: GlucoTrack recently announced closing of private placement.
- What GlucoTrack Does: GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics.
- 交易：GlucoTrack, Inc.（纳斯达克股票代码：GCTK）董事德鲁·西科夫共收购了182,540股股票，平均价格为1.26美元。知情人士花费了约23万美元购买了这些股票。
- 发生了什么：GlucoTrack最近宣布结束私募配售。
- GlucoTrack 做什么：GlucoTrack Inc 是一家医疗器械公司。它专注于非侵入性血糖监测设备的设计、开发和商业化，供糖尿病患者和糖尿病前期患者使用。
Check This Out: Jim Cramer Says This Energy Stock Is 'Terrific,' Calls Casey's General Stores A 'Winner'
看看这个：吉姆·克莱默说这只能源股 “太棒了”，称凯西的杂货店为 “赢家”